Skip to content

Diagnosis and evaluation of therapy in Apraxia of Speech

Diagnosis and evaluation of therapy in Apraxia of Speech - Diagnosis of Apraxia of Speech

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32882
Enrollment
100
Registered
2009-02-18
Start date
2008-11-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurologische hersenaandoeningen Apraxia of Speech

Interventions

None listed

Sponsors

Rijksuniversiteit Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients have suffered from a CVA - Patients are older than 18 and are able to give informed consent - Patients suffer from speech- and or language deficits due to the CVA - Patients have a normal hearing or vision (glasses are allowed) - Patients have Dutch as mothertongue (dialect is allowed) - Patients are right-handed

Exclusion criteria

Exclusion criteria: - Patients suffered from speech or language deficits before brain injury - patients are older than 75 - patients suffer from severe attentional deficits

Design outcomes

Primary

MeasureTime frame
Proper diagnosis and evaluation of the effect of therapy are very important for the treatment of speech and language deficits. For the patient suffering from a speech disorder the main aim of treatment is optimal communication. A specific kind of treatment, like for example SMTA, is assumed to largely contribute to an improvement of communication and by this to an improvement of the quality of life. In order to show the effectiveness of a therapy, both a valid diagnostic instrument and a measure that can determine improvement are necesarry.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)